Early signs of ADHD in preschool children
Part of Mental health clinical trials.
This study looks for early signs (biomarkers) in the blood or behavior that could help identify ADHD in preschool-age children. It compares children with ADHD to those without, to improve early diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 years and 5 years and 11 months old.
- For the ADHD group: your child must have a formal ADHD diagnosis (using DSM-5 criteria).
- For the ADHD group: your child must not have taken any ADHD medication before.
- For the ADHD group: your child must be followed at the Child and Adolescent Psychiatry Department of Robert Debré Hospital in Paris.
- For the control group: your child must have no known developmental or behavioral conditions.
- All children: no intellectual disability (IQ below 70), and parental consent is required.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how mental effort affects children and teens with ADHD. It may help doctors understand ADHD better and improve care.
This study looks at immune system cells in the blood of children with ADHD. It aims to understand how these cells might be different, which could lead to new treatment ideas.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
This study looks at how sleep patterns relate to ADHD symptoms and thinking skills in children. It helps find out if a child's internal clock (circadian rhythm) might be delayed.
This trial tests an early intervention program for young children (about ages 3 to 5) with clinically significant attention and behavior symptoms. It may help by targeting ADHD-related difficulties seen at home and school.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.